Effect of an interactive, educational app about venous thromboembolism and anticoagulation on patient satisfaction: A randomized controlled trial

Thromb Res. 2022 Jan:209:86-93. doi: 10.1016/j.thromres.2021.11.028. Epub 2021 Dec 7.

Abstract

Background: Adequate patient education is essential for patients to engage in shared decision-making when deciding to stop or continue anticoagulation after 3 months for venous thromboembolism (VTE). Our objectives were to evaluate the effect of an interactive, educational app on patients' level of satisfaction with information, perceived level of knowledge, decisional conflict and extent of shared decision-making when deciding on treatment duration of VTE.

Materials and methods: This randomized controlled trial in 1 academic and 3 general Dutch hospitals included adult patients diagnosed with VTE without malignancy or prolonged anticoagulation for other indications. Patients were randomized in 1:1 ratio to receive the app (intervention group) in addition to hospital-specific standard of care. The app, created for this study, contains information on VTE and anticoagulation on an interactive timeline. In the week preceding the consultation when treatment duration is decided, patients were provided with daily videos using push notifications. Outcomes were assessed through self-reported questionnaires at baseline, 1-2 days before and 1 day after consultation. Data were analyzed using t-tests and linear mixed models for repeated measurements.

Results: Data of 56 patients were analyzed (mean age 57 ± 13; 27% female). On a numeric rating scale from 0 to 10, patients who received the app were 0.9 points (95%CI 0.0-1.7; p 0.04) more satisfied with the provided information. Patients who received the app experienced significantly less decisional conflict. No differences in other outcomes were observed.

Conclusions: An educational app about VTE and anticoagulation increases patients' satisfaction and reduces decisional conflict when deciding on treatment duration of VTE. This study was registered in the Netherlands Trial Register (NL7037).

Keywords: Anticoagulant agents; Patient education; Patient satisfaction; Randomized controlled trial; Venous thromboembolism.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Anticoagulants / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mobile Applications*
  • Neoplasms*
  • Surveys and Questionnaires
  • Venous Thromboembolism* / drug therapy

Substances

  • Anticoagulants